Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with reduced major adverse cardiovascular events among patients with critical limb ischemia

Angiotensin converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) are recommended for secondary prevention in peripheral artery disease, but their effectiveness in patients with critical limb ischemia (CLI) is uncertain. We reviewed 464 patients with CLI who underwent diagnost...

Full description

Saved in:

Bibliographic Details
Published in:	Vascular medicine (London, England) Vol. 20; no. 3; pp. 237 - 244
Main Authors:	Armstrong, Ehrin J, Chen, Debbie C, Singh, Gagan D, Amsterdam, Ezra A, Laird, John R
Format:	Journal Article
Language:	English
Published:	London, England SAGE Publications 01.06.2015 Sage Publications Ltd
Subjects:	Aged Angiotensin Receptor Antagonists - therapeutic use Angiotensin-Converting Enzyme Inhibitors - therapeutic use Cardiovascular Diseases - etiology Cardiovascular Diseases - prevention & control Critical Illness Female Follow-Up Studies Humans Ischemia - complications Leg - blood supply Male Proto-Oncogene Proteins Receptors, G-Protein-Coupled Retrospective Studies Time Factors peripheral artery disease critical limb ischemia guideline therapies adherence angiotensin converting enzyme inhibitor angiotensin receptor blocker prevention
ISSN:	1358-863X, 1477-0377
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!